VOLIBRIS Trademark

Trademark Overview

On Monday, November 22, 2004, a trademark application was filed for VOLIBRIS with the United States Patent and Trademark Office. The USPTO has given the VOLIBRIS trademark a serial number of 78521251. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 2, 2009. This trademark is owned by Myogen, Inc.. The VOLIBRIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders in the cardiovascular, cardiac, vascular and hematology fields
volibris

General Information

Serial Number78521251
Word MarkVOLIBRIS
Filing DateMonday, November 22, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 2, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders in the cardiovascular, cardiac, vascular and hematology fields

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 1, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGILEAD COLORADO, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWESTMINSTER, CO 80021
Party NameMyogen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestminster, CO 800215426
Party NameMyogen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestminster, CO 800215426

Trademark Events

Event DateEvent Description
Monday, March 2, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 2, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 29, 2008EXTENSION 5 GRANTED
Tuesday, July 29, 2008EXTENSION 5 FILED
Tuesday, July 29, 2008TEAS EXTENSION RECEIVED
Thursday, January 24, 2008ASSIGNED TO EXAMINER
Wednesday, November 21, 2007EXTENSION 4 GRANTED
Wednesday, November 21, 2007EXTENSION 4 FILED
Wednesday, November 21, 2007TEAS EXTENSION RECEIVED
Friday, September 14, 2007EXTENSION 3 GRANTED
Friday, July 13, 2007EXTENSION 3 FILED
Friday, July 13, 2007TEAS EXTENSION RECEIVED
Tuesday, March 27, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 16, 2007EXTENSION 2 GRANTED
Monday, January 8, 2007EXTENSION 2 FILED
Monday, January 8, 2007TEAS EXTENSION RECEIVED
Wednesday, December 13, 2006AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, June 16, 2006EXTENSION 1 GRANTED
Friday, June 2, 2006EXTENSION 1 FILED
Friday, June 2, 2006TEAS EXTENSION RECEIVED
Tuesday, January 31, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2005PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2005NOTICE OF PUBLICATION
Friday, September 9, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 15, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 8, 2005DATA MODIFICATION COMPLETED
Monday, August 8, 2005DATA MODIFICATION COMPLETED
Monday, August 1, 2005PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, July 1, 2005ASSIGNED TO LIE
Tuesday, June 28, 2005PAPER RECEIVED
Monday, June 27, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 27, 2005EXAMINERS AMENDMENT E-MAILED
Monday, June 27, 2005EXAMINERS AMENDMENT -WRITTEN
Monday, June 27, 2005ASSIGNED TO EXAMINER
Wednesday, December 1, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

volibris cardiac vascular hematology fields cardiovascular disorders preparations treatment diseases pharmaceutical